Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray

scientific article

Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/JIR645
P932PMC publication ID3203236
P698PubMed publication ID21990424
P5875ResearchGate publication ID51709992

P50authorJun WanQ55137372
P2093author name stringHeng Zhu
Jiang Qian
Gary S Hayward
Jian Zhu
Richard F Ambinder
Gangling Liao
S Diane Hayward
Yong Gu Cho
Otoniel Martinez-Maza
Crystal Woodard
Dasheng Zheng
Chuang-Jiun Chiou
Leyao Wang
Shweta Pai
P2860cites workProteins of purified Epstein-Barr virusQ37621844
Non–AIDS-Defining Malignancies in Patients with HIV in the HAART EraQ37838813
Proteome-wide analysis of the serological response to vaccinia and smallpoxQ38432898
A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancerQ38518045
Geographic Heterogeneity of Prevalence of the Human Herpesvirus 8 in Sub-Saharan Africa: Clues About EtiologyQ38871413
Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysisQ39683622
Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinomaQ39952661
Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynxQ39986542
B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirusQ40110061
Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virusQ40727982
Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infectedQ40962673
Characterization of a latent protein encoded by the large internal repeats and the BamHI Y fragment of the Epstein-Barr virus (EBV) genomeQ42649422
No correlation in Epstein-Barr virus reactivation between serological parameters and viral loadQ42726648
Infectious human herpesvirus 8 in a healthy North American blood donorQ44132374
Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.Q45398580
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinomaQ45629039
Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinomaQ45640598
Salivary production of IgA and IgG to human herpes virus 8 latent and lytic antigens by patients in whom Kaposi's sarcoma has regressedQ45653934
Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcomaQ45747380
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinomaQ45750458
Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donorsQ47688207
Screening for family members of patients with nasopharyngeal carcinomaQ50751206
Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assayQ53909009
Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrumQ57262055
Human herpesvirus 8 genomes and seroprevalence in United States blood donorsQ82583545
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcomaQ28284765
The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral outputQ28752465
KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiationQ30433391
Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjectsQ31078772
Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven diseaseQ33629888
Mucosal shedding of human herpesvirus 8 in men.Q33924644
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt"Q33952679
Comparison of serologic assays for detection of antibodies against human herpesvirus 8.Q33999426
Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCRQ34340317
Sexual Transmission and the Natural History of Human Herpesvirus 8 InfectionQ34462040
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivoQ34553645
Severe acute respiratory syndrome diagnostics using a coronavirus protein microarrayQ34572875
Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.Q35824288
Kaposi's sarcoma and its associated herpesvirusQ36487309
Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.Q36637195
Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre studyQ36677160
Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcriptsQ36696963
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.Q36697762
A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytesQ36886069
Epstein-Barr virus: a paradigm for persistent infection - for real and in virtual realityQ37105232
Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4Q37192108
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in bloodQ37198986
Kaposi's sarcoma-associated herpesvirus transmission and primary infectionQ37429716
U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2Q37579511
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectEpstein–Barr virusQ6900
P304page(s)1683-1691
P577publication date2011-10-11
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleComparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray
P478volume204

Reverse relations

cites work (P2860)
Q28385995Application of Proteomics to Soft Tissue Sarcomas
Q36668535Development of Whole-Virus Multiplex Luminex-Based Serological Assays for Diagnosis of Infections with Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Homologs in Macaques
Q39474152Domestic cats seropositive for Felis catus gammaherpesvirus 1 are often qPCR negative
Q27021572Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature
Q42332100FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status.
Q27025953Functional protein microarray as molecular decathlete: a versatile player in clinical proteomics
Q35133590Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome
Q28297010Immunoproteomics: Current Technology and Applications
Q27026000KSHV: pathways to tumorigenesis and persistent infection
Q35013894Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases
Q97067564Network-Based Analysis of OMICs Data to Understand the HIV-Host Interaction
Q36523994ORF33 and ORF38 of Kaposi's Sarcoma-Associated Herpesvirus Interact and Are Required for Optimal Production of Infectious Progeny Viruses
Q54261416Patterns of inter-individual variability in the antibody repertoire targeting proteins across the Epstein-Barr virus proteome.
Q36791459Quantitative determinations of anti-Kaposi sarcoma–associated herpesvirus antibody levels in men who have sex with men
Q36145066Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus
Q33633451Recent 5-year Findings and Technological Advances in the Proteomic Study of HIV-associated Disorders
Q36178032The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma
Q45101653The antibody response to Epstein–Barr virions is altered in multiple sclerosis

Search more.